Nathalia D. Prihoda

Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Journal of Vaccines & Vaccination · 2010 · 20 citations · Full text

Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok, and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT

Nathalia D. Prihoda, Olga V. Arjanova, L. V. Yurchenko et al. · Journal of Medicinal Plants Research · 2007 · 18 citations · Full text

Tuberculosis Prevention, Immunology, Pharmacotherapy +18

Adjunct Oral Immunotherapy in Patients with Re-Treated, Multidrug-Resistant or HIV-Coinfected TB

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V Yurchenko et al. · Immunotherapy · 2010 · 16 citations

Clinical Symptoms, Immunodeficiencies, Tuberculosis Prevention +19

Adjuvant Immunotherapy of Extensively Drug-Resistant Tuberculosis (XDR-TB) in Ukraine

Nathalia D. Prihoda, Olga V. Arjanova, Larisa V Yurchenko et al. · Current Research in Tuberculosis · 2008 · 12 citations · Full text

Vaccination, Pulmonary Tuberculosis, Adjuvant Immunotherapy +8

Comparative effect of an immunomodulator Immunoxel (DzhereloT) when used alone or in combination with antiretroviral therapy in drug-naive HIV-infected individuals

Revaz Chkhetiany, Vladimir Pylipchuk, Olga Argzanova et al. · International Journal of Biotechnology · 2007 · 10 citations